Back to top
more

MDxHealth SA (MDXH)

(Delayed Data from NSDQ)

$2.83 USD

2.83
4,284

-0.03 (-1.05%)

Updated Jul 18, 2024 03:21 PM ET

After-Market: $2.80 -0.03 (-1.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (71 out of 250)

Industry: Medical Info Systems

Better trading starts here.

Zacks News

Agiliti (AGTI) Q4 Earnings Beat Estimates

Agiliti (AGTI) delivered earnings and revenue surprises of 8.33% and 0%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

DermTech, Inc. (DMTK) Reports Q4 Loss, Misses Revenue Estimates

DermTech, Inc. (DMTK) delivered earnings and revenue surprises of -3.70% and 3.11%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Viatris (VTRS) Beats Q3 Earnings Estimates

Viatris (VTRS) delivered earnings and revenue surprises of 5.41% and 1.01%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) Soars 9.9%: Is Further Upside Left in the Stock?

Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Pediatrix Medical Group (MD) Lags Q3 Earnings and Revenue Estimates

Pediatrix Medical Group (MD) delivered earnings and revenue surprises of -25.58% and 0.43%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Avantor, Inc. (AVTR) to Report a Decline in Earnings: What to Look Out for

Avantor, Inc. (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MDxHealth SA Sponsored ADR (MDXH) Expected to Beat Earnings Estimates: Should You Buy?

MDxHealth SA Sponsored ADR (MDXH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MDxHealth SA Sponsored ADR (MDXH) Reports Q2 Loss, Tops Revenue Estimates

MDxHealth SA Sponsored ADR (MDXH) delivered earnings and revenue surprises of 6.25% and 10.58%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Cano Health, Inc. (CANO) Reports Q2 Loss, Lags Revenue Estimates

Cano Health, Inc. (CANO) delivered earnings and revenue surprises of -211.11% and 8.47%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

AMN Healthcare Services (AMN) Beats Q2 Earnings and Revenue Estimates

AMN Healthcare (AMN) delivered earnings and revenue surprises of 10.70% and 0.36%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

MDxHealth SA Sponsored ADR (MDXH) Reports Q1 Loss, Tops Revenue Estimates

MDxHealth SA Sponsored ADR (MDXH) delivered earnings and revenue surprises of 87.50% and 6.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

PerkinElmer (PKI) Q1 Earnings Surpass Estimates

PerkinElmer (PKI) delivered earnings and revenue surprises of 2.02% and 1.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AMN Healthcare Services (AMN) Surpasses Q1 Earnings and Revenue Estimates

AMN Healthcare (AMN) delivered earnings and revenue surprises of 5.51% and 1.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Premier, Inc. (PINC) Q3 Earnings Match Estimates

Premier, Inc. (PINC) delivered earnings and revenue surprises of 0% and 8.69%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Avantor, Inc. (AVTR) to Report a Decline in Earnings: What to Look Out for

Avantor, Inc. (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: MDxHealth SA Sponsored ADR (MDXH) Q1 Earnings Expected to Decline

MDxHealth SA Sponsored ADR (MDXH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Elevance (ELV) to Divest Life & Disability Business to StanCorp

With the sale of the life and disability business, Elevance Health (ELV) is focusing on growing its more profitable operations.

Is a Surprise Coming for MDxHealth (MDXH) This Earnings Season?

MDxHealth (MDXH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.